ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
According to ASP Isotopes Inc. Common Stock's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.63. At the end of 2022 the company had a P/B ratio of 5.78.
Year | P/B ratio |
---|---|
2023 | 3.63 |
2022 | 5.78 |
2021 | 15.29 |
2019 | 0.00 |